Buy glyxambi?

Glyxambi Availability and Pricing

Glyxambi is a medication developed by Boehringer Ingelheim, in partnership with Eli Lilly and Company. It combines empagliflozin and linagliptin to treat type 2 diabetes [1]. To purchase Glyxambi, you can obtain it through various channels, including:

- Prescription-only: You can get Glyxambi through a prescription from your doctor or healthcare provider. They'll assess your medical condition and recommend the best course of treatment.

- Pharmacies: Glyxambi is available at pharmacies, including major chains and independent stores. You can also purchase it online through authorized retailers, but be aware that prices might vary.

- Cost and Insurance: The cost of Glyxambi can be covered partially or entirely by insurance, depending on your plan. You can contact your insurance provider to determine the extent of coverage.

- Patient Assistance Programs: Boehringer Ingelheim offers a patient assistance program (PAP) to help eligible patients access Glyxambi. The program provides free or reduced-cost medication to individuals who meet certain income and insurance criteria.

Glyxambi Patent Information

According to DrugPatentWatch.com [2], Glyxambi's patent is set to expire in 2027 in the United States. This timeline may change due to patent disputes, regulatory delays, or court decisions.

Why Choose Glyxambi?

Glyxambi combines two effective medications to treat type 2 diabetes. It can lead to better blood sugar control and reduced risk of complications. Your doctor will help you understand the benefits and potential risks of using Glyxambi.

Glyxambi Side Effects

Be aware that Glyxambi may cause side effects, such as increased risk of genital yeast infections, dehydration, and low blood pressure. Your doctor will monitor you for these and other potential issues.

Glyxambi vs. Other Medications

When choosing a treatment for type 2 diabetes, it's essential to discuss the pros and cons of Glyxambi with your doctor. They can help determine the best course of treatment based on your individual needs and medical history.

Sources:

[1] Boehringer Ingelheim and Eli Lilly and Company. (n.d.). Empagliflozin and linagliptin - Glyxambi. Retrieved from https://www.boehringer-ingelheim.com/our-business/pipeline/glyxambi-em-pa-gli-flo-zin-and-linagliptin.html

[2] DrugPatentWatch.com. (n.d.). Glyxambi Patent Expiration Dates. Retrieved from https://www.drugpatentwatch.com/drug/Glyxambi